scholarly journals An ultraportable and versatile point-of-care DNA testing platform

2020 ◽  
Vol 6 (17) ◽  
pp. eaaz7445 ◽  
Author(s):  
Huan Xu ◽  
Anyue Xia ◽  
Dandan Wang ◽  
Yiheng Zhang ◽  
Shaoli Deng ◽  
...  
Keyword(s):  
Signal Amplification ◽  
Point Of Care ◽  
Clinical Diagnostics ◽  
Dna Testing ◽  
Point Of Care Testing ◽  
Resource Limited Settings ◽  
Single Base ◽  
Signal Detector ◽  
Resource Limited ◽  
Different Types

Point-of-care testing (POCT) has broad applications in resource-limited settings. Here, a POCT platform termed POCKET (point-of-care kit for the entire test) is demonstrated that is ultraportable and versatile for analyzing multiple types of DNA in different fields in a sample-to-answer manner. The POCKET is less than 100 g and smaller than 25 cm in length. The kit consists of an integrated chip (i-chip) and a foldable box (f-box). The i-chip integrates the sample preparation with a previously unidentified, triple signal amplification. The f-box uses a smartphone as a heater, a signal detector, and a result readout. We detected different types of DNA from clinics to environment to food to agriculture. The detection is sensitive (<103 copies/ml), specific (single-base differentiation), speedy (<2 hours), and stable (>10 weeks shelf life). This inexpensive, ultraportable POCKET platform may become a versatile sample-to-answer platform for clinical diagnostics, food safety, agricultural protection, and environmental monitoring.

The Next Phase for Point-of-Care Testing in Resource-Limited Settings

2016 ◽  
Vol 15 (2) ◽  
pp. 93-95 ◽  
Author(s):  
Lee F. Schroeder ◽  
Paul LaBarre ◽  
Bernhard Hans Weigl ◽  
Timothy Amukele
Keyword(s):  
Point Of Care ◽  
Point Of Care Testing ◽  
Resource Limited Settings ◽  
Resource Limited

scholarly journals Point-of-Care Testing for Infectious Diseases: Past, Present, and Future

2017 ◽  
Vol 55 (8) ◽  
pp. 2313-2320 ◽  
Author(s):  
Thomas R. Kozel ◽  
Amanda R. Burnham-Marusich
Keyword(s):  
Infectious Diseases ◽  
New Technologies ◽  
Point Of Care ◽  
Low Cost ◽  
Ease Of Use ◽  
Lateral Flow Immunoassay ◽  
Point Of Care Testing ◽  
Resource Limited Settings ◽  
Resource Limited ◽  
Potential Use

ABSTRACT Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system. The usual platform has been the lateral flow immunoassay. Recently, emerging molecular diagnostics have met requirements for speed, low cost, and ease of use for POC applications. A major driver for POC development is the ability to diagnose infectious diseases at sites with a limited infrastructure. The potential use in both wealthy and resource-limited settings has fueled an intense effort to build on existing technologies and to generate new technologies for the diagnosis of a broad spectrum of infectious diseases.

Paper-based multiplexed vertical flow assay for point-of-care testing

Lab on a Chip ◽  
2019 ◽  
Vol 19 (6) ◽  
pp. 1027-1034 ◽  
Author(s):  
Hyou-Arm Joung ◽  
Zachary S. Ballard ◽  
Alice Ma ◽  
Derek K. Tseng ◽  
Hailemariam Teshome ◽  
...  
Keyword(s):  
Diagnostic Tool ◽  
Point Of Care ◽  
Vertical Flow ◽  
Point Of Care Testing ◽  
Resource Limited Settings ◽  
Resource Limited

The developed platform could serve as a diagnostic tool for point-of-care Lyme diagnosis and can be applied to other diagnoses which require a multiplexed measurement in resource-limited settings.

scholarly journals Validation of a point-of-care rapid diagnostic test for hepatitis C for use in resource-limited settings

2019 ◽  
Vol 11 (4) ◽  
pp. 314-315
Author(s):  
James S Leathers ◽  
Maria Belen Pisano ◽  
Viviana Re ◽  
Gertine van Oord ◽  
Amir Sultan ◽  
...  
Keyword(s):  
Point Of Care ◽  
Low Cost ◽  
Rapid Diagnosis ◽  
Direct Acting Antivirals ◽  
Resource Limited Settings ◽  
Rapid Diagnosis Test ◽  
Resource Limited ◽  
Specificity And Sensitivity ◽  
Hcv Screening ◽  
Direct Acting

Abstract Background Treatment of HCV with direct-acting antivirals has enabled the discussion of HCV eradication worldwide. Envisioning this aim requires implementation of mass screening in resource-limited areas, usually constrained by testing costs. Methods We validated a low-cost, rapid diagnosis test (RDT) for HCV in three different continents in 141 individuals. Results The HCV RDT showed 100% specificity and sensitivity across different samples regardless of genotype or viral load (in samples with such information, 90%). Conclusions The HCV test validated in this study can allow for HCV screening in areas of need when properly used.

scholarly journals HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies

Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1125
Author(s):  
Sontaga Manyana ◽  
Lilishia Gounder ◽  
Melendhran Pillay ◽  
Justen Manasa ◽  
Kogieleum Naidoo ◽  
...  
Keyword(s):  
Drug Resistance ◽  
Sanger Sequencing ◽  
Clinical Diagnostics ◽  
Treatment Programs ◽  
People Living With Hiv ◽  
Resource Limited Settings ◽  
Gold Standard Method ◽  
Sequencing Technologies ◽  
Resource Limited ◽  
Hiv 1

Affordable, sensitive, and scalable technologies are needed for monitoring antiretroviral treatment (ART) success with the goal of eradicating HIV-1 infection. This review discusses use of Sanger sequencing and next generation sequencing (NGS) methods for HIV-1 drug resistance (HIVDR) genotyping, focusing on their use in resource limited settings (RLS). Sanger sequencing remains the gold-standard method for detecting HIVDR mutations of clinical relevance but is mainly limited by high sequencing costs and low-throughput. NGS is becoming a more common sequencing method, with the ability to detect low-abundance drug-resistant variants and reduce per sample costs through sample pooling and massive parallel sequencing. However, use of NGS in RLS is mainly limited by infrastructure costs. Given these shortcomings, our review discusses sequencing technologies for HIVDR genotyping, focusing on common in-house and commercial assays, challenges with Sanger sequencing in keeping up with changes in HIV-1 treatment programs, as well as challenges with NGS that limit its implementation in RLS and in clinical diagnostics. We further discuss knowledge gaps and offer recommendations on how to overcome existing barriers for implementing HIVDR genotyping in RLS, to make informed clinical decisions that improve quality of life for people living with HIV.

scholarly journals Disposable Voltammetric Immunosensors Integrated with Microfluidic Platforms for Biomedical, Agricultural and Food Analyses: A Review

Sensors ◽  
2018 ◽  
Vol 18 (12) ◽  
pp. 4124 ◽  
Author(s):  
Fabiana Felix ◽  
Alexandre Baccaro ◽  
Lúcio Angnes
Keyword(s):  
Quality Management ◽  
Signal Amplification ◽  
Screen Printing ◽  
Point Of Care ◽  
Microfluidic Devices ◽  
Strong Interactions ◽  
Point Of Care Testing ◽  
Microfluidic Platforms ◽  
Broad Variety ◽  
Interesting Alternative

Disposable immunosensors are analytical devices used for the quantification of a broad variety of analytes in different areas such as clinical, environmental, agricultural and food quality management. They detect the analytes by means of the strong interactions between antibodies and antigens, which provide concentration-dependent signals. For the herein highlighted voltammetric immunosensors, the analytical measurements are due to changes in the electrical signals on the surface of the transducers. The possibility of using disposable and miniaturized immunoassays is a very interesting alternative for voltammetric analyses, mainly, when associated with screen-printing technologies (screen-printed electrodes, SPEs), and microfluidic platforms. The aim of this paper is to discuss a carefully selected literature about different examples of SPEs-based immunosensors associated with microfluidic technologies for diseases, food, agricultural and environmental analysis. Technological aspects of the development of the voltammetric immunoassays such as the signal amplification, construction of paper-based microfluidic platforms and the utilization of microfluidic devices for point-of-care testing will be presented as well.

Multi-Angle Lensfree Holographic Imaging for 3-D Cytometry on a Chip

2010 ◽  
Author(s):  
Ting-Wei Su ◽  
Serhan O. Isikman ◽  
Waheb Bishara ◽  
Derek K. Tseng ◽  
Anthony Erlinger ◽  
...  
Keyword(s):  
Optical Microscopy ◽  
Biomedical Applications ◽  
Point Of Care ◽  
Resource Limited Settings ◽  
Holographic Imaging ◽  
Essential Tool ◽  
Resource Limited

Optical microscopy is an essential tool for many biomedical applications. Although commonly-used in laboratory settings, conventional optical microscopes are bulky and relatively costly to use in resource-limited settings which partially limit their use in point-of-care applications.

Sign in / Sign up

Export Citation Format

Share Document